These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 944861)

  • 1. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine.
    Shaywitz BA; Klopper JH; Yager RD; Gordon JW
    Nature; 1976 May; 261(5556):153-5. PubMed ID: 944861
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs.
    Arnold LE; Kirilcuk V; Corson SA; Corson EO
    Am J Psychiatry; 1973 Feb; 130(2):165-70. PubMed ID: 4568123
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical effects of amphetamine on preweanling and postweanling rats.
    Campbell BA; Randall PJ
    Science; 1977 Mar; 195(4281):888-91. PubMed ID: 557236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperactivity in developing rats: sex differences in 6-hydroxydopamine and amphetamine effects.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1981 Jan; 14(1):5-10. PubMed ID: 7193330
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 8. How amphetamine acts in minimal brain dysfunction.
    Snyder SH; Meyerhoff JL
    Ann N Y Acad Sci; 1973 Feb; 205():310-20. PubMed ID: 4570236
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction.
    Shaywitz BA; Yager RD; Klopper JH
    Science; 1976 Jan; 191(4224):305-8. PubMed ID: 942800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 12. Nerve growth factor: effects on D-amphetamine-induced activity and brain monoamines.
    Lewis ME; Brown RM; Brownstein MJ; Hart T; Stein DG
    Brain Res; 1979 Nov; 176(2):297-310. PubMed ID: 40668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changed eating and locomotor behaviour in the rat after 6-hydroxydopamine lesions to the substantia nigra.
    Brook C; Iversen SD
    Neuropharmacology; 1975 Feb; 14(2):95-105. PubMed ID: 1171387
    [No Abstract]   [Full Text] [Related]  

  • 14. Paradoxical dextroamphetamine response.
    Arnold LE
    Psychosomatics; 1981 Sep; 22(9):805. PubMed ID: 7313058
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine.
    White NM
    Life Sci; 1988; 43(1):7-12. PubMed ID: 3133532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine-induced motility and nigrostriatal impulse flow.
    Gonzalez LP; Ellinwood EH
    Brain Res; 1981 Mar; 208(1):223-6. PubMed ID: 6258746
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
    Nowak P; Kostrzewa RM; Kwieciński A; Bortel A; Labus Ł; Brus R
    J Physiol Pharmacol; 2005 Jun; 56(2):325-33. PubMed ID: 15985712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Brain monoamines and the increase in motor activity in the rat after amphetamine.
    Guldberg HC; Marsden CA
    Br J Pharmacol; 1972 Feb; 44(2):347P-348P. PubMed ID: 4668615
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.